Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Kim, Dae‐Young; Joo, Young‐Don; Lim, Sung-Nam; Kim, Sung-Doo; Lee, Jung‐Hee; Lee, Je‐Hwan; Kim, Dong‐Hwan; Kım, Kihyun; Won Jung, Chul; Kim, Inho; Yoon, Sung‐Soo; Park, Seonyang; Ahn, Jae‐Sook; Yang, Deok‐Hwan; Lee, Je‐Jung; Sup Lee, Ho; Soo Kim, Yang; Mun, Yeung‐Chul; Kim, Hawk; Hoo Park, Jae; Ho Moon, Joon; Kyun Sohn, Sang; Min Lee, Sang; Sik Lee, Won; Ha Kim, Kyoung; Won, Jong-Ho; Soo Hyun, Myung; Park, Jinny; Hoon Lee, Jae; Shin, Ho‐Jin; Chung, Joo-Seop; Lee, Hyewon; Eom, Hyeon‐Seok; Won Lee, Gyeong; Cho, Young‐Uk; Jang, Seongsoo; Park, Chan‐Jeoung; Chi, Hyun‐Sook; Lee, Kyoo‐Hyung

doi:10.1182/blood-2015-03-636548

Public

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Published in Blood • Jun 11, 2015

Authors:

Dae‐Young Kim

Young‐Don Joo

Sung-Nam Lim

Abstract

We investigated the effects of nilotinib plus multiagent chemotherapy, followed by consolidation/maintenance or allogeneic hematopoietic cell transplantation (allo-HCT) for adult patients with newly diagnosed Philadelphia-positive (Ph-pos) acute lymphoblastic leukemia (ALL). Study subjects received ...

Subject

Nilotinib

Lymphoblastic Leukemia

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!